BIS vs. RSPN
Compare and contrast key facts about ProShares UltraShort Nasdaq Biotechnology (BIS) and Invesco S&P 500® Equal Weight Industrials ETF (RSPN).
BIS and RSPN are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BIS is a passively managed fund by ProShares that tracks the performance of the NASDAQ Biotechnology Index (-200%). It was launched on Apr 7, 2010. RSPN is a passively managed fund by Invesco that tracks the performance of the S&P 500® Equal Weight Industrials Index. It was launched on Jan 11, 2006. Both BIS and RSPN are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BIS or RSPN.
Performance
BIS vs. RSPN - Performance Comparison
Returns By Period
In the year-to-date period, BIS achieves a -5.05% return, which is significantly lower than RSPN's 27.43% return. Over the past 10 years, BIS has underperformed RSPN with an annualized return of -21.30%, while RSPN has yielded a comparatively higher 11.72% annualized return.
BIS
-5.05%
7.27%
-3.97%
-28.39%
-21.63%
-21.30%
RSPN
27.43%
5.84%
17.01%
38.12%
15.64%
11.72%
Key characteristics
| BIS | RSPN | |
|---|---|---|
| Sharpe Ratio | -0.79 | 2.72 |
| Sortino Ratio | -1.05 | 3.81 |
| Omega Ratio | 0.89 | 1.47 |
| Calmar Ratio | -0.28 | 6.60 |
| Martin Ratio | -0.97 | 15.98 |
| Ulcer Index | 29.40% | 2.39% |
| Daily Std Dev | 35.96% | 14.02% |
| Max Drawdown | -99.77% | -61.64% |
| Current Drawdown | -99.73% | -0.82% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BIS vs. RSPN - Expense Ratio Comparison
BIS has a 0.95% expense ratio, which is higher than RSPN's 0.40% expense ratio.
Correlation
The correlation between BIS and RSPN is -0.51. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.
Risk-Adjusted Performance
BIS vs. RSPN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Nasdaq Biotechnology (BIS) and Invesco S&P 500® Equal Weight Industrials ETF (RSPN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BIS vs. RSPN - Dividend Comparison
BIS's dividend yield for the trailing twelve months is around 3.89%, more than RSPN's 0.86% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
BIS ProShares UltraShort Nasdaq Biotechnology | 3.89% | 1.75% | 0.00% | 0.00% | 0.44% | 2.10% | 0.37% |
RSPN Invesco S&P 500® Equal Weight Industrials ETF | 0.86% | 0.55% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
BIS vs. RSPN - Drawdown Comparison
The maximum BIS drawdown since its inception was -99.77%, which is greater than RSPN's maximum drawdown of -61.64%. Use the drawdown chart below to compare losses from any high point for BIS and RSPN. For additional features, visit the drawdowns tool.
Volatility
BIS vs. RSPN - Volatility Comparison
ProShares UltraShort Nasdaq Biotechnology (BIS) has a higher volatility of 13.62% compared to Invesco S&P 500® Equal Weight Industrials ETF (RSPN) at 5.31%. This indicates that BIS's price experiences larger fluctuations and is considered to be riskier than RSPN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.